Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2013 Results
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
NANJING, China, May 9, 2013 — NANJING, China, May 9, 2013 /PRNewswire/ -- Simcere Pharmaceutical Group ("Simcere" or the "Company") (NYSE: SCR), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported preliminary unaudited financial results for the quarter ended March 31, 2013.
Help employers find you! Check out all the jobs and post your resume.
NANJING, China, May 9, 2013 — NANJING, China, May 9, 2013 /PRNewswire/ -- Simcere Pharmaceutical Group ("Simcere" or the "Company") (NYSE: SCR), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported preliminary unaudited financial results for the quarter ended March 31, 2013.
Help employers find you! Check out all the jobs and post your resume.